Abstract
Ferrite nanoparticles have been widely used in the biomedical field (such as magnetic targeting, magnetic resonance imaging, magnetic hyperthermia, etc.) due to their appealing magnetic properties. In tumor acidic microenvironment, ferrite nanoparticles show intrinsic peroxidase-like activities, which can catalyze the Fenton reaction of hydrogen peroxide (H2O2) to produce highly toxic hydroxyl free radicals (•OH), causing the death of tumor cell. Recent progresses in this field have shown that the enzymatic activity of ferrite can be improved via converting external field energy such as alternating magnetic field and near-infrared laser into nanoscale heat to produce more •OH, enhancing the killing effect on tumor cells. On the other hand, combined with other nanomaterials or drugs for cascade reactions, the production of reactive oxygen species (ROS) can also be increased to obtain more efficient cancer therapy. In this review, we will discuss the current status and progress of the application of ferrite nanoparticles in ROS-mediated cancer therapy and try to provide new ideas for this area.
Introduction
Cancer is one of the principal causes of morbidity and mortality in every country of the world. According to global cancer statistics of the World Health Organization, there were 18.1 million new cancer cases and 9.6 million cancer deaths in 2018, with the number of new cases rising 42.5% compared to that in 2008 (12.7 million) (Bray et al., ). In order to prevent the uncontrollable growth of tumor cells, the most conventional cancer therapeutic approaches used in clinical practice now are still surgery, chemotherapy, radiotherapy, and combination of them (Vahrmeijer et al., ; Barton et al., ; Prigerson et al., ; Sullivan et al., ; Sharma et al., ). However, surgery is often ineffective for advanced and metastasized cancers. Chemotherapy and radiotherapy suffer from severe side effects on account of the toxicity to normal cells and tissues. Based on the research of cancer-related biology and the development of biomedical engineering, a variety of alternative treatment strategies have been extensively studied to obtain more efficient cancer therapy, such as magnetic hyperthermia, photothermal therapy, photodynamic therapy, immunotherapy, and gene therapy (Dolmans et al., ; Yang et al., ; Kumar and Mohammad, ; Pardoll, ; Topalian et al., ; High and Roncarolo, ; Liu et al., ). Most of these treatment strategies need to rely on the regulation of reactive oxygen species (ROS) to mediate tumor cell death. ROS are categorized as a class of incomplete reduction products of oxygen, mainly including superoxide anion (), hydrogen peroxide (H2O2), hydroxyl radical (•OH), and singlet oxygen (1O2) (Kumari et al., ). Superoxide anion can be generated as a byproduct of the electron transport chain in mitochondria or through activation of nicotinamide adenine dinucleotide phosphate oxidase (NOX) and exogenous stimulation (Murphy, ). Superoxide dismutase can reduce superoxide to hydrogen peroxide, which can be further converted into non-oxidizing water by cytosolic antioxidant systems under the catalysis of catalase, peroxiredoxins, and glutathione peroxidase (Winston and Giulio, ). The balance between the production and neutralization of reactive oxygen species in normal cells is beneficial to maintaining a proper ROS concentration to regulate intracellular signaling and homeostasis (Forman et al., ). Reactive oxygen species at high levels can damage proteins, lipids, and DNA, resulting in mutations and carcinogenesis in normal cells (Trachootham et al., ). Compared with normal cells, most tumor cells metabolize in distinct pathways leading to excessive ROS production (Schumacker, ). Cancer cells also have a higher level of antioxidant enzymes to enable them to survive in the presence of intrinsic oxidative stress without apoptosis (Birben et al., ). Increasing generation, regulating the types of reactive oxygen species, and inhibiting cellular glutathione peroxidase can break the balance between the production and elimination of ROS in tumor cell and tune the function of intracellular ROS from tumor promoting toward apoptotic signaling, inducing the apoptosis and death of tumor cell for cancer therapeutics (Liou and Storz, ). In order to enhance the effect of ROS-mediated tumor-specific therapeutic, various drugs and nanomaterials such as doxorubicin, cisplatin, Fe3O4, gold, silver, polyoxomolybdate (POM), and molybdenum carbide have been studied for targeted delivery to tumor tissues and endocytosis by tumor cells to selectively increase the production of highly toxic ROS in tumor cells (Yanagie et al., ; He et al., , ; Maji et al., ; Kankala et al., ; Feng et al., ; Liu et al., ; Dong et al., ; Maiti et al., ). Among these nanomaterials, ferrite nanoparticles are widely studied due to unique magnetic properties and relatively high safety to human body, especially iron oxide nanoparticles, which have been approved by the US Food and Drug Administration for clinical applications, such as iron supplement, magnetic resonance contrast agent, and drug carrier (Liu et al., ). Ferrite nanomaterials are composed of main ferric oxide and one or more oxides of other metals (such as manganese, copper, nickel, cobalt, or zinc). In tumor acidic microenvironment, ferrite nanoparticles exhibit peroxidase-like activity, which can catalyze the Fenton reaction of H2O2 to produce highly toxic •OH, inducing the death of tumor cell (Chen et al., ). The peroxidase activity depends on the intrinsic properties of ferrite nanoparticles (chemical composition, crystalline phase, and particle size) and ROS-related bio-microenvironmental factors (physiological pH and buffers, biogenic reducing agents, and other organic substances). For further reading these factors in detail, an excellent review has been published by Yin and colleagues (Wu et al., ). In this review, we summarized the advances in the application of ferrite nanoparticles in ROS-mediated cancer therapy, and constructive perspectives were also provided.
Ferrite-Based ROS-Mediated Cancer Therapy
In 2007, Yan et al. first discovered that Fe3O4 nanoparticles possess intrinsic peroxidase-like activity, which can catalyze the disproportionation of H2O2 to produce highly toxic •OH (Gao et al., ). Subsequently, researchers conducted extensive investigation on ferrite nanomaterials as nanoenzyme to mediate the generation of ROS for tumor treatment (Mai and Hilt, ). The specific mechanisms of the sufficient and highly toxic ROS production under the catalysis of ferrite nanoparticles in the existing publications can be roughly summarized as the following (shown in Scheme 1): (1) the intrinsic Fenton reaction catalytic activity of ferrite nanomaterials, (2) external field energy enhanced Fenton reaction, and (3) the cascade reactions to generate sufficient ROS.
Scheme 1
Intrinsic Fenton Reaction of Ferrite
The intrinsic Fenton reaction catalytic activity is the most important mechanism of ferrite nanoparticles for ROS-mediated tumor therapy. Ferrite nanoparticles can specifically accumulate at the tumor site via enhanced permeability and retention effect and magnetic targeting and simultaneously release ferrous and ferric ions in tumor acidic environment to participate in the Fenton reaction with H2O2 and generate •OH (Wang et al., ). The Fenton and Fenton-like reactions can be shown as the following equations: (1); (2) (Bokare and Choi, ). The intrinsic catalytic activity of ferrite nanoparticles can be flexibly designed and controlled by adjusting the particles composition, size, morphology, etc.
Wang et al. pioneered the study of magnetic nanoparticles for tumor treatment (Zhang et al., ). They synthesized 6 and 13 nm magnetite nanoparticles (MNPs) through a one-pot method, which possessed enzyme-mimicking activity to produce ROS efficiently for cancer theranostics. The smaller size MNPs had higher enzyme-mimicking activity, and an ~99% tumor inhibition ratio was obtained by combining with intratumoral injection of exogenous hydrogen peroxide after treatment for 17 days. The size dependence of the catalytic activity of ferrite nanoparticles was further studied by Liu and colleagues. They investigated the cytotoxic effects of small Fe3O4 nanoparticles with different diameters (6, 9, and 14 nm) on human hepatoma cell lines, SK-Hep-1 and Hep3B (Xie et al., ). The 9 nm Fe3O4 nanoparticles mediated mitochondria-dependent intracellular ROS generation to induce cellular mitochondrial dysfunction and necrosis, while the 14 nm Fe3O4 nanoparticles led to plasma membrane damage. Luo et al. obtained similar results that a suitable size (15.1 nm) of superparamagnetic iron oxide nanoparticles (SPIONs) enhanced the uptake amount into MCF7 cells, leading to the formation of more ROS (Zhang et al., ). Promoted ROS was produced in mitochondria to destroy mitochondria by small size (7.3 nm) SPIONs, while more ROS was yield in plasma to destroy cytomembrane by larger size (15.1, 30.0 nm) SPIONs. As can be seen from the above description, the size may affect the distribution of the nanoparticles. It would be more efficient if the ferrite nanoparticles can be delivered to the desired area. Zhu et al. developed a pH-responsive iron oxides-loaded mesoporous silica nanosystem (FeOx-MSNs), which could deliver FeOx to lysosomes and release Fe2+/Fe3+ in acidic environment to catalyze the decomposition of H2O2 to generate considerable ROS to damage breast carcinoma cells efficiently (Figure 1) (Fu et al., ).
Figure 1
The morphology has a significant impact on the properties of nanomaterials. Li et al. fabricated Fe3O4 nanoparticles with nanocluster, nanoflower, and nanodiamond structures by tuning the pH of the hydrothermal reaction (Figure 2) (Fu et al., ). The structure has a great influence on peroxidase-like activity, following the order of nanocluster > nanoflower > nanodiamond. However, nanodiamonds had the highest cellular endocytosis (43.2, 20.8, and 18.8% of the added nanoparticles for nanodiamonds, nanoclusters, and nanoflowers, respectively). The cell viability data indicated that the cancer cell killing activity of the Fe3O4 nanoparticles was induced by the generated intracellular ROS through the Fenton reaction with H2O2, which was codetermined by the cell endocytosis of the nanoparticles and their enzyme-like activity.
Figure 2
Non-ferrous metal species such as copper, zinc, and iridium are widely used to regulate the performance of ferrite nanoparticles. Alshamsan et al. prepared copper ferrite nanoparticles, which could induce evident oxidative stress by ROS generation and glutathione depletion, triggering the death of human breast cancer MCF-7 cells (Ahamed et al., ). Liao et al. also incorporated copper into ferrite nanoparticles to regulate the H2O2 catalytic ability (Kuo et al., ). They changed the loading amount of iron precursor concentration to control the Fe/Cu ratio of the CuFe NPs. The Combination of Fe and Cu in the oxide form could enhance the conversion of H2O2 to ROS, and the optimal Fe/Cu ratio was 2. Chuang et al. synthesized SnFe2O4 nanocrystals with sonication treatment, which could be delivered through inhalation for lung cancer therapy (Figure 3) (Lee et al., ). The lattice ferric ions can convert endogenous H2O2 into highly toxicity •OH to effectively eradicate cancer cells through heterogeneous Fenton reaction. Wang et al. treated the cancer cells with iridium and Fe2+ ions to biosynthesize the biocompatible iridium oxide and iron oxide nanoclusters under the redox microenvironment (Shaikh et al., ). Their results demonstrated that U87 and HepG2 cells incubated with Ir–Fe significantly increased the ROS generation compared to Ir ions alone, triggering the apoptosis to inhibit tumor growth. Siddiqui et al. compared the cytotoxic activity of copper oxide (CuO), iron oxide (γFe2O3), and zinc, iron, and copper oxide (CuZnFe2O3) in human breast cancer (MCF-7) cells (Siddiqui et al., ). The increase in ROS level could be important mechanism of metal oxide nanoparticles-induced cytotoxicity in cancer cells. The above-mentioned results fully indicated that single and multimetal oxide nanoparticles exhibited differential cytotoxic responses in cancer cells, and the ROS production could be regulated by the chemical composition of nanomaterials.
Figure 3
Surface modification also plays an important role in the preparation, stability, and activity of ferrite nanoparticles. Tiku synthesized phyllanthus emblica-coated iron oxide nanoparticles (IONPAs) using a green approach (Thoidingjam and Tiku, ). The phyllanthus emblica could act as stabilizing agents by binding to the surfaces of the formed IONPs, so that IONPA was smaller in size with better dispersibility, leading to higher uptake in A549 lung cancer cells to produce more ROS to induce higher DNA damage and apoptosis. Small molecule coatings may significantly change the surface properties of the nanoparticles, which is needed to be considered in designing the nanoplatforms for cancer therapy. Hilt et al. observed that small molecule (citric acid, sodium phosphate, aminosilane, or dopamine) coatings could decrease surface reactivity of IONPs and inhibit ROS generation (Mai and Hilt, ). Conversely, Liu et al. reported that carboxy-functional Fe2O3 nanoparticles (Fe2O3@DMSA) with negative zeta potential had higher cellular uptake efficiency, which promoted intracellular iron-retention-induced ROS production but inhibited the fusion of lysosomes and autophagosomes to enhance tumoricidal autophagy for cancer therapy (Figure 4) (Xie et al., ). Ge et al. developed a novel ellipsoidal composite nanoplatform using a magnetic Fe3O4/Fe nanorod core enwrapped by a catalase-imprinted fibrous SiO2/polydopamine shell (Fe3O4/Fe@F-SiO2/PDA) (Chen et al., ). The catalase-imprinted shell can selectively inhibit the activity of catalase to elevate H2O2 level, which could be converted into •OH under the catalysis of Fe ions released by Fe3O4/Fe core, triggering apoptosis to effectively kill MCF-7, 293T, and Hela tumor cells combined with the near-infrared light photothermal effect of the polydopamine layer. Targeting and responsive molecules assembled on the surface of nanoparticles can improve delivery efficiency and selectivity. Horak et al. prepared magnetic and temperature-sensitive solid lipid particles (mag. SLPs) using oleic acid-coated iron oxide, 1-tetradecanol, and poly(ethylene oxide)-block-poly(E-caprolactone), which could melt down in the tumorous tissue to produce more ROS than the non-magnetic SLPs and neat iron oxides, inducing apoptosis of Jurkat leukemic cells (Swietek et al., ). Sawant et al. developed novel pH responsive and mitochondria targeted poly-l-lysine-coated Fe3O4@FePt core shell nanoparticles (Mito-PANPs) (Pandey et al., ). Mitochondria directing triphenylphsphonium ion mediated the delivery of nanoparticles to mitochondria, enhancing ROS generation to provide multimodal therapy for glioblastomas. The gradient core–shell structure is widely used to modify the surface of functional nanomaterials. Hou et al. developed a pH-sensitive nanoreactor based on core–shell-structured iron carbide nanoparticles with amorphous Fe3O4 shells (Fe5C2@Fe3O4). The amorphous Fe3O4 shells were less stable against dissolution and able to release ferrous ions in acidic environments to generate •OH through the Fenton reaction of H2O2, effectively inhibiting the proliferation of tumor cells (Yu et al., ).
Figure 4
The effect of ROS-mediated tumor therapy can be significantly improved by combining ferrite nanoparticles with chemotherapeutic drugs, chemical or biological agents, etc. Bahadur et al. developed PEGylated mesoporous iron platinum–iron oxide composite nanoassemblies with high loading capacity of doxorubicin, which exhibited a higher efficiency of ROS generation compared to Fe3O4 and Pt under the synergistic catalytic effect of FePt and Fe3O4, resulting in efficient chemo- and thermal therapy for Hela cancer cells (Sahu et al., ). Yeh et al. presented an H2O2-loaded ultrasound contrast agent H2O2/Fe3O4-poly(D,L-lactide-co-glycolic acid (PLGA) polymersome, which could yield sufficient •OH through the Fenton reaction of encapsulated H2O2 and Fe3O4, completely removing the malignant tumors in a non-thermal process (Li et al., ). Watanabe et al. investigated the combined effects of Fe3O4 nanoparticles with chemotherapeutic agents (rapamycin or carboplatin) on prostate cancer cells in vitro (Kojima et al., ). Synergistic effect of Fe3O4 NPs was observed in DU145 cells with carboplatin and in PC-3 cells with rapamycin, increasing intracellular ROS levels to decrease cancer cell viability significantly. Hou et al. designed a PLGA-polymer matrix coated with Fe/FeO core–shell nanocrystals and coloaded with chemotherapy drug and photothermal agent (DOX-ICG@Fe/FeO-PPP-FA nanocapsules), which could in situ overproduce ROS by reacting with endogenous H2O2 in tumors, overcoming the tumor hypoxia-related resistance of chemotherapy and photodynamic therapy (Figure 5) (Wang et al., ). Liu et al. developed a facile synergistic nanoplatform (NanoTRAIL) using iron oxide cluster and tumor necrosis factor-related apoptosis-inducing ligand (TRAI/Apo2L), which could release iron oxide NPs to generate ROS to provoke JNK-autophagy-dependent DR5 upregulation, leading to enhancing TRAIL/Apo2L-induced apoptosis in colorectal cancer (Shi et al., ). Thenmozhi prepared PVP-coated iron oxide nanoparticles loaded with syzygium aromaticum extract, which could induce oxidative stress via ROS formation, enhancing MCF-7 breast cancer apoptosis (Thenmozhi, ). This interesting study of the application of biomass syzygium aromaticum extract can provide a useful reference for the application researches of traditional Chinese medicine.
Figure 5
The applicability of ROS-mediated treatment to different types of cancers has been extensively verified. Ahamed et al. prepared spherical iron oxide nanoparticles with a smooth surface and an average diameter of 23 nm, which could induce the reactive oxygen species generation in HepG2 and A549 cancer cells, upregulating tumor suppressor gene p53 and caspase-3 and caspase-9 apoptotic genes to trigger cancer cells apoptosis (Ahamed et al., ). In subsequent research, they found that the MCF-7 cells were slightly more sensitive to nickel ferrite nanoparticles than liver HepG2 cells induced by reactive oxygen species (Ahamed et al., ). Gokduman synthesized magnetite iron oxide nanoparticles with a diameter of ~20 nm, which could increase intracellular ROS, enhancing the anticancer activity of cisplatin by increasing the apoptosis of the cisplatin-resistant ovarian cancer cells (OVCAR-3 and SKOV-3) (Gokduman, ). Rajesh et al. developed a hybrid magnetic microsphere system (Fe3O4@LEC-CUR-PLGA-MMS) using iron oxide nanoparticle (Fe3O4 NP), lecithin (LEC), curcumin (CUR), PLGA, and polyethylene glycol (PEG) (Ayyanaar et al., ). The Fe3O4 could catalyze the generation of ROS in an H2O2 environment to release the CUR, showing greater cytotoxicity against A549 and HeLa S3 cells. Salehzadeh et al. synthesized Fe3O4@CPTMOS/TP NPs, which had an effect on induction of apoptosis and inhibition of the growth of gastric AGS cancer cells by increasing ROS production in the treated cells (Habibzadeh et al., ). The IC50 value in AGS cells was estimated to be 95.65 μg/ml. Ramalingam et al. prepared hematite α-Fe2O3 by wet chemical method, which showed dose-dependent anticancer activity against human metastatic ovarian cancer (OC) by inducing ROS generation, damaging the mitochondrial membrane, and triggering the apoptosis of OC PA-1 cells (Ramalingam et al., ). Pourahmad et al. investigated the effect of SPIONs on the oral tongue squamous cell carcinoma (OTSCC) (Jahanbani et al., ). SPIONs were able to increase the level of ROS formation in cancerous mitochondria to selectively initiate ROS-mediated apoptosis of SCC cells. As can be seen from the above descriptions, ROS-mediated therapies based on ferrite nanoparticles have broad applicability to a wide range of cancers.
The study of mechanisms and pathways for ROS-mediated cancer therapy based on ferrite nanoparticles has also attracted the attention of researchers. Liu et al. investigated the molecular mechanism of SPIONs induced cancer-cell-specific cytotoxicity through DNA microarray and bioinformatics analyses (He et al., ). SPIONs can interfere with the mitochondrial electron transport chain to induce the formation of ROS, triggering cytotoxicity to the cancer cells. Han et al. reported that ultrasmall 9 nm Fe3O4 NPs could effectively internalize into cells and locate in the nucleus and induce ROS production and oxidative damage by disturbing the expression of antioxidant-related genes, suggesting a potential antitumor application (Ye et al., ). Ma et al. demonstrated polyethyleneimine-coated Fe3O4 magnetic nanoparticles (PEI-MNPs), which could contribute to ROS overproduction by the Fenton reaction, resulting in autophagy induction via mTOR-Akt-p70S6 K and ATG7 signaling pathways to kill cancer cells (Figure 6) (Man et al., ). Further research on the mechanism will be beneficial to the development of more effective ferrite nanoparticle-based therapeutic agents.
Figure 6
External Field Enhanced Fenton Reaction
Only relying on the intrinsic Fenton reaction catalytic activity of ferrite nanomaterials often requires a high concentration to generate enough ROS to kill tumor cells, which may increase the burden of iron removal based on the kidney and liver and cause adverse damage to the body (Ranji-Burachaloo et al., ). External electromagnetic waves such as X-ray, near-infrared light and alternating magnetic field can be absorbed by the ferrite-based nanoplatform to improve the production of reactive oxygen species (Laurent et al., ; Pilar Vinardell and Mitjans, ; Xiong et al., ). Ultrasound, a typical high-frequency mechanical wave, can also be used as an external energy source. Gorgizadeh et al. synthesized a nickel ferrite/carbon nanocomposite (NiFe2O4/C) as sonosensitizer (Gorgizadeh et al., ). Radiation of ultrasound into NiFe2O4/C effectively induced cavitation formation and ROS production, resulting in remarkable efficacious recovery in mouse melanoma cancer model by intratumorally injection at dosage of ~100 mg kg−1.
Kryschi et al. first studied the citrate-coated superparamagnetic iron oxide nanoparticles as X-ray radiosensitizer (Klein et al., ). The increased catalytically active iron oxide nanoparticle surfaces can enhance the ROS generation for about 240% under the X-ray exposure. In subsequent research, they synthesized 9–20 nm (γFe2O3)1−x(Fe3O4)x surface stabilized with citrate or malate anions, which can drastically enhance the ROS concentration of more than 300% via the Fenton reaction in 1 Gy X-ray-irradiated tumor cells (Klein et al., ). Hadjipanayis et al. showed that cetuximab-conjugated iron oxide nanoparticles (cetuximab-IONPs) could sensitize ionizing radiation therapy by increasing ROS formation and DNA double strands breaks (Bouras et al., ). Hilt et al. developed a cell-penetrating peptide functionalized iron oxide nanoparticle (TAT-Fe3O4) to increase the efficacy of radiation therapy (Hauser et al., ). Radiation promoted the production of the superoxide anion in mitochondria, which was further converted to hydrogen peroxide by superoxide dismutase, and the generated H2O2 could be catalyzed to the highly reactive hydroxyl radical by the Fenton reaction with iron oxide nanoparticles for the enhancement of radiation therapy. Kryschi et al. synthesized functionalized superparamagnetic magnetite (Fe3O4) and Co-ferrite (CoFe2O4) nanoparticles with self-assembled monolayer coatings, which have long-term stability and could be activated through X-ray exposure with a single dosage of 1 Gy to induce ablation of the surface coverage and release either Fe2+ or Co2+ ions, enhancing the production of the highly hydroxyl radical via the Fenton reaction to kill the cancerous MCF-7 cells efficiently (Figure 7) (Klein et al., ).
Figure 7
Light waves are also widely used as external field energy sources. Near-infrared light irradiation can be efficiently converted into heat to enhance ROS generation. Miao et al. synthesized Zn2+-doped magnetic nanoparticles via hydrothermal route, which revealed excellent photothermal effect to generate localized heat and increase the dissolution of magnetic nanoparticles in the acid medium to enhance ROS generation upon a near-infrared (NIR) light irradiation, inducing cancer treatment (Qi et al., ). Chen et al. confirmed that the bacterial magnetic nanoparticles could induce increased level of intracellular ROS along with heat under near-infrared light irradiation to trigger an efficient tumor cell kill (Chen et al., ). Dong et al. fabricated a nanoplatform based on iron oxide nanoparticles, indocyanine green, and hyaluronic acid (IONPs-ICG-HA) (Wang et al., ). The iron oxide could convert intracellular H2O2 to generate fatal reactive oxygen species through Fenton reaction, which could be boosted by increased temperature of photothermal effect of ICG, enhancing synergistic phototherapy in cancer treatment. Li et al. developed a tumor-targeting iron sponge γGDYO-Fe3O4-CREKA (TTIS) nanocomposite, which could accelerate the release of iron ions to enhance the efficiency of the Fenton reaction and generate more ROS by the heat produced in the process of photothermal therapy (Min et al., ). You et al. designed a more stable and high-ROS-yielding Pt/Fe3O4@SP-PLGA lipo-polymersom, which could significantly increase the generation of •OH for ROS-mediated cancer therapy through the reaction between succinic peroxide (SP) and iron oxide under NIR irradiation (You et al., ). Photosensitizers can be activated by laser irradiation to improve the electron–hole pairs separation efficacy and redox potentials, leading to strong ability in generating ROS. Ji et al. prepared 2D ultrathin Z-scheme highly oxidized ilmenite nanosheets (FeTiO3@Fe2O3) with much strong oxidation and reduction potentials in the valence band (VB) of Fe2O3 and the conduction band (CB) of FeTiO3, which could enhance the generation of from O2 on the CB of FeTiO3 and •OH from H2O2 on the VB of Fe2O3 for antitumor therapy under irradiation of 650 nm laser (Figure 8) (Ou et al., ).
Figure 8
Ferrite nanoparticles have unique magnetic heating transfer efficiency to generate heat, enhancing the effect of ROS-mediated cancer therapy (Johannsen et al., ; Silva et al., ). The alternating magnetic field is the most commonly used due to its large penetration. Hilt et al. showed that peptide-conjugated magnetic nanoparticles (TAT-IONP) could increase cellular ROS generation in both A549 and H358 cell lines upon exposure to an alternating magnetic field, resulting in an increase in apoptosis via the Caspase 3/7 pathways (Hauser et al., ). Orel et al. designed magnetic nanodots composed of doxorubicin-loaded Fe3O4 nanoparticles, which could release more free iron to promote the formation of highly reactive oxygen species combined with electromagnetic fields, achieving remote modulation of redox state of Walker-256 carcinosarcoma tumor for cancer nanotherapy (Orel et al., ). Lin et al. synthesized magnetic hydroxyapatite nanoparticles by coprecipitation with the addition of Fe2+ (mHAP), which could increase intracellular ROS concentration to cause DNA damage of HepG2 cells with possible MKK3/MKK6 and ATF-2 of p38 MAPK inhibition under exposure to alternating magnetic field (Yang et al., ). Zhang et al. designed a magnetic hydrogel nanozyme utilizing PEGylated Fe3O4 nanoparticles and a-cyclodextrin, which could enhance tumor oxidative stress level by generating more ROS through promoted peroxidase-like enzymatic activity of Fe3O4 nanozyme at 42 hyperthermia induced by a non-invasive external alternating current magnetic field (Wu et al., ). Fan et al. demonstrated a biocompatible elaborate ferrimagnetic vortex-domain iron oxide nanoring and graphene oxide hybrid nanoparticle (FVIOs-GO-CREKA), which had high thermal conversion efficiency to significantly amplify the generation of ROS under an alternating magnetic field, promoting macrophage polarization to proinflammatory M1 phenotypes and elevating tumor-infiltrating T lymphocytes to provoke a strong immune response at a physiological tolerable temperature below 40 in a hypoxic tumor microenvironment (Figure 9) (Liu et al., ). Hilger et al. reported that the magnetic heating treatment could induce more production of ROS and alter messenger RNA (mRNA) expression of Ki-67, TOP2A, and TPX2, resulting in reducing tumor volumes superior to that of extrinsic heating (hot air) significantly (Ludwig et al., ). The effect of treatment under static magnetic field has also attracted the interest of researchers. Pazik et al. investigated the viability of canine mastocytoma tumor cells cultured with cobalt–manganese ferrite nanoparticles (Co0.2Mn0.8Fe2O4) under 0.5 T static magnetic field (Marycz et al., ). The nanoparticles and magnetic field increase the temperature of tumor cells and the formation of reactive oxygen species, inducing apoptotic response.
Figure 9
Multifield coupling can often produce better synergistic therapeutic effects. Hassan et al. designed nanohybrid using nanoflower-like iron oxide and spiky copper sulfide shell (IONF@CuS), which could efficiently convert light and magnetic stimulation into heat and form concurrent reactive oxygen species upon laser irradiation for a tri-therapeutic strategy merging magnetic hyperthermia and photothermal and photodynamic therapy (Curcio et al., ). Fan et al. designed biocompatible Fe3O4-Pd Janus nanoparticles, which could enhance ROS generation due to the interface synergistic effect in producing hydroxyl radicals by Fe3O4 nanoparticle-based Fenton reaction and Pd nanosheet-based catalytic properties under external alternating magnetic field plus laser irradiation, exhibiting a high tumor-inhibition efficacy [100% tumor inhibition rate at a dose of 6 mg kg−1 under alternating magnetic field (AMF) (300 kHz; 300 Oe) and laser (808 nm; 0.5 W cm−2)] toward 4T1 orthotopic breast tumor (Figure 10) (Ma et al., ). Sharma et al. developed manganese doped-iron oxide nanoclusters, which could trigger heat-induced enhancement of the Fenton reaction for the generation of •OH under the dual application of magnetic hyperthermia and photothermal stimulation, resulting in a remarkable anticancer effect mediated by ROS-dependent apoptosis via the mitochondrial pathway (Gupta and Sharma, ).
Figure 10
Cascade Reactions Increased ROS
The rapid growth of the tumor tissues and the incomplete blood vessels lead to a hypoxia environment within solid tumors (Knowles and Harris, ). The concentration of intratumoral H2O2 is generally considered to be as low as 50–100 μM, which is not high enough to generate an effective amount of hydroxyl radicals for a satisfactory cancer therapy (Chen et al., ). Intratumoral injection of hydrogen peroxide is an effective method to increase the ROS-mediated tumor therapeutic effect (Zhang et al., ). However, this method has poor controllability and safety, causing damage to the surrounding healthy tissues. The cascade reactions have shown a good prospect in overcoming the tumor hypoxia and increasing the ROS production.
The most commonly used strategy is to generate more intratumoral hydrogen peroxide in situ through cascade reactions for the subsequent Fenton reaction. The β-lapachone was used earlier in such cascade reactions, which could undergo redox cycles to generate high H2O2 levels inside cancer cells. Gao et al. developed pH-responsive superparamagnetic iron oxide nanoparticles (SPION micelles), which could selectively release iron ions in tumor acidic environment to react with H2O2 generated from β-lapachone to produce 10-fold highly active hydroxyl radicals, displaying a synergistic efficacy for cancer treatment with ROS-generating anticancer drug (Huang et al., ). In another similar study, Chen et al. constructed a nanomedicine by encapsulating β-lapachone (La) and IONPs into the hydrophobic core of nanostructure formed by polyprodrug and polymer, which could be internalized by tumor cells and disintegrated in acidic environment to release La and iron ions (Wang et al., ). The released La generated massive H2O2 through the catalysis of the nicotinamide adenine dinucleotide (phosphate) [NAD(P)H]: quinone oxidoreductase 1 (NQO1), which would further be converted to highly toxic •OH by Fenton reaction with iron ions, resulting in improved antitumor activity. Ascorbic acid, a known antioxidant, can also be used to produce endogenous H2O2. Wang et al. synthesized Fe3O4@C nanoparticles modified with folic acid (Fe3O4@C-FA), which could create hydroxyl radicals from H2O2 yielded by the exogenous ascorbic acid, inducing the selective killing of cancer cells owing to ROS accumulation in human prostate cancer PC-3 cells (An et al., ). In a similar study, as low as 0.1 mM exogenous vitamin C was catalyzed by iron oxide nanoparticle to generate H2O2 followed by ROS production in the form of hydroxyl/superoxide radicals, inducing effective tumor cell death (Pal and Jana, ). Cisplatin is also commonly used as cascade reaction trigger agent. Lin et al. constructed self-sacrificing iron oxide nanoparticles with cisplatin (IV) prodrug (FePt-NP2), which could release cisplatin and Fe2+/Fe3+ (Ma et al., ). The released cisplatin could activate nicotinamide adenine dinucleotide phosphate (NADPH) oxidase to trigger oxygen to generate superoxide radical, which could be further dismutated by superoxide dismutase to form downstream H2O2. The generated H2O2 would be catalyzed by Fe2+/Fe3+ to the toxic hydroxyl radicals, causing ROS-mediated oxidative damages to lipids, proteins, and DNA and inducing tumor cell apoptosis. This strategy was also adopted by Chen et al. to design cisplatin-loaded Fe3O4/Gd2O3 hybrid nanoparticles with conjugation of lactoferrin and RGD dimer (FeGd-HN@Pt@LF/RGD2), which could release cisplatin, Fe2+, and Fe3+ after endocytosis in the endosomes, leading to high inhibition efficacy on orthotopic brain tumors (Shen et al., ). Ni et al. synthesized FA/Pt+si-GPX4@IONPs for gene treatment of glioblastoma (Zhang et al., ). The cascade reactions triggered by Pt laid the foundation for efficient ROS production to induce a combination of ferroptosis and apoptosis. Another cascade reaction strategy developed by Shi et al. reported a sequential catalytic nanomedicine using natural glucose oxidase and synthetic ultrasmall Fe3O4 nanoparticles to integrate into the large mesopores of dendritic mesoporous silica nanoparticles (GFD NCs) (Huo et al., ). The glucose oxidase (GOD) released from nanocatalysts could deplete the glucose to produce considerable amounts of H2O2, which could be converted into highly toxic hydroxyl radical through Fenton-like reaction catalyzed by Fe3O4 nanoparticles to trigger the apoptosis and death of tumor cells. This strategy was further studied by Ge et al. They engineered ultrasmall iron oxide nanoparticles (USIONs) and GOD-coloaded PEG-b-P(CPTKMA-co-PEMA) polymersomes nanoreactors (Fe/G@R-NRs), which could occur cascade reactions including glucose consumption to generate H2O2 by GOD, production of •OH through Fenton reaction between H2O2 and iron ion released by USIONs, and ·OH-triggered rapid release of polyprodrug for orchestrated cooperative cancer therapy including starving therapy, chemodynamic therapy, and chemotherapy (Figure 11) (Ke et al., ). Xu et al. developed glucose oxidase and polydopamine-functionalized iron oxide nanoparticles (Fe3O4@PDA/GOx NPs), in which the enzymatic activity of GOx was stably retained due to the excellent biocompatibility of polydopamine (Zhang et al., ). For cancer cells incubated with the 200 nm NPs, the •OH accumulation within the cells was about 2-fold higher than that with 20 nm NPs treatment, efficiently inducing the apoptosis of cancer cells. Peroxide can be employed as potent H2O2 supplier to sustain the ferrite nanoparticles-mediated Fenton reaction. Shi et al. constructed 2D multifunctional therapeutic nanoreactors by conjugating iron oxide nanoparticles and calcium peroxide onto niobium carbide (Nb2C-IO-CaO2) (Gao et al., ). The CaO2 could react with H2O to produce H2O2 in the acidic tumor microenvironment, which was subsequently disproportionated into highly toxic •OH by the IO nanoparticles for inducing tumor cell death. With laser irradiation, graphene oxide can produce more reactive graphene radicals to enhance the ROS formation. Huang et al. developed a near-infrared absorbing nanoagent using graphene oxide loaded with iron hydroxide/oxide (GO-FeOxH) via one-step electrooxidation (He et al., ). The electron transfer from GO to the Fe3+ of FeOxH could promote the reaction with O2 to generate superoxide anion radicals under NIR light irradiation, which would be converted into
Figure 11
H2O2 through disproportionation reaction. The generated H2O2 then underwent a reaction with Fe2+ of FeOxH to produce amplified hydroxyl radicals, triggering near-infrared activated ROS-mediated photodynamic therapy.
Ferrite nanoparticles are also used to catalyze the production of molecular oxygen to overcome tumor hypoxia, improving the ROS-mediated tumor therapeutic effect. Hyeon et al. designed manganese ferrite nanoparticle anchored mesoporous silica nanoparticles loaded with molecule chlorin e6 (MFMSNs-Ce6) (Kim et al., ). The manganese ferrite could catalyze decomposition of H2O2 to evolve O2, which could be further converted to singlet oxygen by photosensitizer Ce6, improving photodynamic therapeutic outcomes for hypoxic tumor. Some similar studies were carried out by other researchers. Lin et al. prepared photosensitizer-loaded and PEG-modified MnFe2O4-decorated large-pore mesoporous silica-coated β-NaYF4:20%Yb,2%Er@β-NaYF4 upconversion nanoparticles (UCMnFe-PS-PEG) as NIR light-mediated and O2 self-sufficient photodynamic therapy (PDT) agents (Ding et al., ). The sub-10 nm MnFe2O4 nanoparticles not only provided magnetic guidance to the tumor but also worked as a Fenton catalyst to generate O2in situ to overcome tumor hypoxia. The tumor growth was greatly inhibited, and some of the tumors even disappeared after 16 days of treatment. A biocompatible nanoplatform [MnFe2O4@metal-organic framework (MOF)] developed by Zhang et al. using a coating of porphyrin-based MOF as the photosensitizer and manganese ferrite nanoparticle (MnFe2O4) as the enzyme can not only catalyze H2O2 to produce O2 to overcome the tumor hypoxia but also consume glutathione, achieving better therapeutic efficacy (Yin et al., ). The tumor growth was considerably suppressed after mice were treated with MnFe2O4@MOF-PEG (i.v. injection of 200 μl, 6.25 mg kg−1 TCPP) and laser irradiation (0.8 W cm−2, 8 min, 24 h post-i.v. injection). Zhang et al. showed “all in one” theranostic agents copper ferrite nanospheres (CFNs), in which the coupling between Fe2+/Fe3+ and Cu+/Cu2+ redox pairs could produce more •OH and O2 through Fenton reactions under 650-nm laser illumination (Liu et al., ). The produced O2 could be further converted into by photogenerated electron/hole pair for synergistic tumor ablation of photoenhanced chemodynamic therapy/photodynamic therapy/photothermal therapy. Lin et al. synthesized a novel nanoplatform composed of hollow iron oxide nanoparticles and hematoporphyrin sonosensitizers (HP-HIONs) (Zhang et al., ). The HIONs possessed nanozyme activity for catalyzing decomposition of hydrogen peroxide to produce O2, which could be further converted to ROS by sonodynamic therapy for efficient cancer cell apoptosis. Wei et al. synthesized iron oxide nanoparticles-loaded stomatocytes@ZnPc nanomotors (ISP-NMs), in which IONPs catalyzed decomposition of endogenous H2O2 to generate O2 as propelling force to expand the distribution of ZnPc (Zhang et al., ). The generated O2 was supplied to produce more ROS (1O2), enhancing PDT performance (Figure 12).
Figure 12
Some other strategies have also been developed to increase ROS generation. Daldrup-Link et al. coincubated adenocarcinoma with iron oxide nanoparticle compound ferumoxytol and macrophages (Zanganeh et al., ). Ferumoxytol nanoparticles increased presence of proinflammatory M1 macrophages in the tumor to enhance the production of hydrogen peroxide and hydroxyl radical for macrophage-modulating cancer immunotherapies (Figure 13). Chen et al. constructed double-layered vesicles with Fe3O4 face-to-face localized in the inner side and Au extended to the outer side by self-assembly of iron oxide–gold Janus nanoparticles (Fe3O4-Au JNPs) using hydrophilic poly(ethylene glycol)-grafted Au and poly(lipid hydroperoxide)-co-poly(4-vinyl pyrene)-coated Fe3O4. In the acidic tumor environment, the vesicles disassembled into single JNPs, allowing Fe3O4 to react with H+ to release Fe2+. The released Fe2+ further reacted with poly(lipid hydroperoxide) to generate reactive oxygen species (1O2) and increase intracellular oxidative stress for better inhibition of tumor growth (Song et al., ).
Figure 13
Conclusion and Future Outlook
In the past nearly 10 years, ROS-mediated cancer therapy using ferrite nanoparticles has been rapidly developed, and researchers have published a large number of related publications (summarized in Table 1). This review was carried on the classification and summarization of the application of ferrite nanoparticles in ROS-mediated cancer therapy. Based on the analysis of the current literature, it can be seen that various modification strategies for the ROS-mediated cancer therapies based on ferrite nanoparticles are producing more and more successful results, especially in combination with drugs, biological and chemical agents, and/or co-exposure of other energy fields such as X-rays, lasers, and alternating magnetic fields, becoming potential effective tumor therapy strategies. However, to date, only iron oxide nanoparticles have been approved for the magnetic response diagnosis and the magnetic hyperthermia tumor therapy (Park et al., ; Shi et al., ). Few clinical trials have been reported for any tumor therapy based on ferrite nanoparticle-induced ROS (Liang et al., ). The ferrite nanoparticle-induced ROS can kill the cancer cell and also can trigger the toxic effect on the normal tissues and vasculature. Therefore, in order to solve this dilemma, on the one hand, the high-performance ferrite nanoparticles should be developed to produce much more ROS so that the dosage of the particles can be reduced. On the other hand, the smart (stimulus-responsive) ferrite nanoparticles should be designed to produce more controllable ROS in tumor tissue and little to no ROS outside tumor tissue.
Table 1
| ROS production | Ferrite-based nanoplatform | Brief description | References |
|---|---|---|---|
| Intrinsic fenton reaction | Fe3O4 (6, 13 nm) | Smaller size, higher enzyme activity | Zhang et al., |
| Fe3O4 (6, 9, and 14 nm) | Small size NPs destroy mitochondria, while larger size destroy cytomembrane | Xie et al., | |
| SPIONs (7.3, 15.1, 30.0 nm) | Zhang et al., | ||
| FeOx-MSNs | pH responsive, delivered to acidic lysosomes | Fu et al., | |
| Fe3O4 nanocluster, nanoflower, and nanodiamond | Fe3O4 nanodiamonds induce the highest cell killing effect | Fu et al., | |
| CuFe2O4 | Non-ferrous metal species regulate the ROS production | Ahamed et al., | |
| MB-CuFe NPs | Kuo et al., | ||
| SnFe2O4 | Lee et al., | ||
| Iridium oxide and iron oxide | Shaikh et al., | ||
| CuO, γFe2O3, CuZnFe2O3 | Siddiqui et al., | ||
| IONPA | Coating reduces nanoparticle size | Thoidingjam and Tiku, | |
| UC-IONP, CA-IONP, SP-IONP, AS-IONP, DA-IONP | Coatings decreases surface reactivity | Mai and Hilt, | |
| Fe2O3@DMSA, Fe2O3@APTS | DMSA-coating promotes uptake efficiency | Xie et al., | |
| Fe3O4/Fe@F-SiO2/PDA | Catalase-imprinted shell inhibits catalase activity to elevate H2O2 level | Chen et al., | |
| mag. SLPs | Targeting molecules, responsive molecules, improved delivery efficiency and selectivity | Swietek et al., | |
| Mito-PANPs | Pandey et al., | ||
| Fe5C2@Fe3O4 | Gradient core-shell structure, differential release | Yu et al., | |
| PEGylated FePt-Fe3O4 + doxorubicin | Combining ferrite nanoparticle and chemotherapeutic drugs, chemical and biological agents, etc. improves ROS-mediated tumor therapy. | Sahu et al., | |
| H2O2/Fe3O4-PLGA polymersome | Li et al., | ||
| Fe3O4 + (rapamycin or carboplatin) | Kojima et al., | ||
| DOX-ICG@Fe/FeO-PPP-FA nanocapsules | Wang et al., | ||
| TRAIL/Apo2L-iron oxide nanoparticles | Shi et al., | ||
| S. aromaticum + PVP + Fe-ONPs | Thenmozhi, | ||
| Iron oxide nanoparticles | Broad applicability to a wide range of cancers: HepG2, A549, MCF-7, OVCAR-3, SKOV-3, HeLa S3, AGS, metastatic OC, OTSCC, etc. | Ahamed et al., | |
| Nickel ferrite nanoparticles | Ahamed et al., | ||
| Magnetite iron oxide nanoparticles | Gokduman, | ||
| Fe3O4@LEC-CUR-PLGA-MMS | Ayyanaar et al., | ||
| Fe3O4@CPTMOS/TP NPs | Habibzadeh et al., | ||
| α-Fe2O3 | Ramalingam et al., | ||
| SPIONs | Jahanbani et al., | ||
| SPIONs | Mechanisms: mitochondrial electron transport chain, antioxidant-related genes, mTOR-Akt-p70S6 K and ATG7, etc. | He et al., | |
| 9 nm Fe3O4 NPs | Ye et al., | ||
| PEI-MNPs | Man et al., | ||
| External field enhanced ROS | NiFe2O4/C | Enhanced by ultrasound | Gorgizadeh et al., |
| Citrate-coated SPIONs | Increased ROS production under X-ray irradiation, etc. | Klein et al., | |
| 9–20 nm (γ-Fe2O3)1−x(Fe3O4)x | Klein et al., | ||
| Cetuximab-IONPs | Bouras et al., | ||
| TAT-Fe3O4 | Hauser et al., | ||
| PA-SAM functionalized Fe3O4 and CoFe2O4 MNPs | Klein et al., | ||
| Zn2+-doped magnetic nanoparticles | Improved catalytic activity under NIR photothermal energy | Qi et al., | |
| Bacterial magnetic nanoparticles | Chen et al., | ||
| IONPs-ICG-HA | Wang et al., | ||
| γGDYO-Fe3O4-CREKA (TTIS) | Nanoplatform depolymerizes under NIR Photothermal energy | Min et al., | |
| Pt/Fe3O4@SP-PLGA | You et al., | ||
| FeTiO3@Fe2O3 | 650 nm laser irradiation formed photoexcited electron–hole | Ou et al., | |
| TAT-IONP | Improved catalytic activity under AMF magnetic heat | Hauser et al., | |
| Doxorubicin-loaded Fe3O4 nanoparticles | Orel et al., | ||
| mHAP | Yang et al., | ||
| Magnetic hydrogel nanozyme (MHZ) | Wu et al., | ||
| FVIOs-GO-CREKA | Liu et al., | ||
| Iron oxide magnetic nanoparticles | Magnetic heating superior to extrinsic hot air heating | Ludwig et al., | |
| Co0.2Mn0.8Fe2O4 | 0.5 T static magnetic field | Marycz et al., | |
| IONF@CuS | Synergistic effect of multi-field coupling (AMF and laser irradiation) | Curcio et al., | |
| Fe3O4-Pd | Ma et al., | ||
| Manganese doped-iron oxide nanoclusters (MNCs) | Gupta and Sharma, | ||
| Cascades increased ROS | SPION micelles | β-lapachone increases H2O2 | Huang et al., |
| LaCIONPs | Wang et al., | ||
| Fe3O4@C-FA | Ascorbic acid increases H2O2 | An et al., | |
| Vitamin C-conjugated Fe3O4 | Pal and Jana, | ||
| FePt-NP2 | Cisplatin activates NADPH oxidase to generate H2O2 | Ma et al., | |
| FeGd-HN@Pt@LF/RGD2 | Shen et al., | ||
| FA/Pt+si-GPX4@IONPs | Zhang et al., | ||
| GFD NCs | Glucose oxidase consumes glucose to generate H2O2 | Huo et al., | |
| Fe/G@R-NRs | Ke et al., | ||
| Fe3O4@PDA/GOx NPs | Zhang et al., | ||
| Nb2C-IO-CaO2 | CaO2 as H2O2 supplier | Gao et al., | |
| GO-FeOxH | Graphene oxide produces ROS under laser irradiation. | He et al., | |
| MFMSNs-Ce6 | Ferrite nanoparticles catalyze decomposition of H2O2 to O2 to overcome tumor hypoxia, improving ROS-mediated cancer therapy. | Kim et al., | |
| UCMnFe-PS-PEG | Ding et al., | ||
| MnFe2O4@MOF-PEG | Yin et al., | ||
| Copper ferrite nanospheres (CFNs) | Liu et al., | ||
| HP-HIONs | Zhang et al., | ||
| ISP-NMs | Zhang et al., | ||
| Ferumoxytol nanoparticles | Ferumoxytol acted on tumor-associated macrophages to adapt an antitumor “M1” phenotype, enhancing macrophage ROS production. | Zanganeh et al., | |
| Fe3O4-Au JNPs self-assembled vesicles | poly(lipid hydroperoxide) reacts with released Fe2+ to generate ROS | Song et al., |
Summary of current ferrite nanoparticles used for ROS-mediated cancer therapy.
Having achieved the excellent performance of ROS-mediated cancer therapy based on ferrite nanoparticles on small animal model, there are still many important challenges before clinical application. First, further studies on the development of strategies for controllable synthesis of ferrite nanoparticles in large scale are needed to satisfy the requirement for clinical translation and commercialization. Second, the biosafety should be fully investigated on large animals, as most of the current ferrite nanoparticles biosafety evaluation in vivo is based on small animals, and the biosafety of the nanoparticles remains largely unexplored in large animals and even in human models. It is appealing to combine efforts from the researchers in the fields of oncology, biochemistry, nanotechnology, medicine, and materials to shed light on the future of ROS-mediated cancer therapy based on ferrite nanoparticles.
Statements
Author contributions
SY, SZ, and MZ wrote the manuscript. SY and HZ revised the manuscript. HF provided useful suggestions. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by National Natural Science Foundation of China (No. 81901908).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AhamedM.AkhtarM. J.AlhadlaqH. A.AlshamsanA. (2016). Copper ferrite nanoparticle-induced cytotoxicity and oxidative stress in human breast cancer MCF-7 cells. Colloids Surf. B-Biointerfaces142, 46–54. 10.1016/j.colsurfb.2016.02.043
2
AhamedM.AkhtarM. J.AlhadlaqH. A.KhanM. A. M.AlrokayanS. A. (2015). Comparative cytotoxic response of nickel ferrite nanoparticles in human liver HepG2 and breast MFC-7 cancer cells. Chemosphere135, 278–288. 10.1016/j.chemosphere.2015.03.079
3
AhamedM.AlhadlaqH. A.KhanM. A. M.AkhtarM. J. (2013). Selective killing of cancer cells by iron oxide nanoparticles mediated through reactive oxygen species via p53 pathway. J. Nanopart. Res.15:1225. 10.1007/s11051-012-1225-6
4
AnQ.SunC.LiD.XuK.GuoJ.WangC. (2013). Peroxidase-like activity of Fe3O4@Carbon nanoparticles enhances ascorbic acid-induced oxidative stress and selective damage to PC-3 prostate cancer cells. ACS Appl. Mater. Interfaces5, 13248–13257. 10.1021/am4042367
5
AyyanaarS.KesavanM. P.BalachandranC.RasalaS.RameshkumarP.AokiS.et al. (2020). Iron oxide nanoparticle core-shell magnetic microspheres: applications toward targeted drug delivery. Nanomed. Nanotechnol. Biol. Med.24:102134. 10.1016/j.nano.2019.102134
6
BartonM. B.JacobS.ShafiqJ.WongK.ThompsonS. R.HannaT. P.et al. (2014). Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother. Oncol.112, 140–144. 10.1016/j.radonc.2014.03.024
7
BirbenE.SahinerU. M.SackesenC.ErzurumS.KalayciO. (2012). Oxidative stress and antioxidant defense. World Allergy Organ. J.5, 9–19. 10.1097/WOX.0b013e3182439613
8
BokareA. D.ChoiW. (2014). Review of iron-free Fenton-like systems for activating H2O2 in advanced oxidation processes. J. Hazard. Mater.275, 121–135. 10.1016/j.jhazmat.2014.04.054
9
BourasA.KaluzovaM.HadjipanayisC. G. (2015). Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles. J. Neurooncol.124, 13–22. 10.1007/s11060-015-1807-0
10
BrayF.FerlayJ.SoerjomataramI.SiegelR. L.TorreL. A.JemalA. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68, 394–424. 10.3322/caac.21492
11
ChenC.WangS.LiL.WangP.ChenC.SunZ.et al. (2016). Bacterial magnetic nanoparticles for photothermal therapy of cancer under the guidance of MRI. Biomaterials104, 352–360. 10.1016/j.biomaterials.2016.07.030
12
ChenJ.LeiS.ZengK.WangM.AsifA.GeX. (2017a). Catalase-imprinted Fe3O4/Fe@fibrous SiO2/polydopamine nanoparticles: An integrated nanoplatform of magnetic targeting, magnetic resonance imaging, and dual-mode cancer therapy. Nano Res.10, 2351–2363. 10.1007/s12274-017-1431-8
13
ChenQ.LiangC.SunX.ChenJ.YangZ.ZhaoH.et al. (2017b). H2O2-responsive liposomal nanoprobe for photoacoustic inflammation imaging and tumor theranostics via in vivo chromogenic assay. Proc. Natl. Acad. Sci. U.S.A.114, 5343–5348. 10.1073/pnas.1701976114
14
ChenZ.YinJ.-J.ZhouY.-T.ZhangY.SongL.SongM.et al. (2012). Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity. ACS Nano6, 4001–4012. 10.1021/nn300291r
15
CurcioA.SilvaA. K. A.CabanaS.EspinosaA.BaptisteB.MenguyN.et al. (2019). Iron oxide nanoflowers @ CuS hybrids for cancer tri-therapy: interplay of photothermal therapy, magnetic hyperthermia and photodynamic therapy. Theranostics9, 1288–1302. 10.7150/thno.30238
16
DingB.ShaoS.XiaoH.SunC.CaiX.JiangF.et al. (2019). MnFe2O4-decorated large-pore mesoporous silica-coated upconversion nanoparticles for near-infrared light-induced and O2 self-sufficient photodynamic therapy. Nanoscale11, 14654–14667. 10.1039/c9nr04858h
17
DolmansD.FukumuraD.JainR. K. (2003). Photodynamic therapy for cancer. Nat. Rev. Cancer3, 380–387. 10.1038/nrc1071
18
DongL. M.YeC.ZhengL. L.GaoZ. F.XiaF. (2020). Two-dimensional metal carbides and nitrides (MXenes): preparation, property, and applications in cancer therapy. Nanophotonics9, 2125–2145. 10.1515/nanoph-2019-0550
19
FengW.WangR.ZhouY.DingL.GaoX.ZhouB.et al. (2019). Ultrathin molybdenum carbide MXene with fast biodegradability for highly efficient theory-oriented photonic tumor hyperthermia. Adv. Funct. Mater.29:1901942. 10.1002/adfm.201901942
20
FormanH. J.MaiorinoM.UrsiniF. (2010). Signaling functions of reactive oxygen species. Biochemistry49, 835–842. 10.1021/bi9020378
21
FuJ.ShaoY.WangL.ZhuY. (2015). Lysosome-controlled efficient ROS overproduction against cancer cells with a high pH-responsive catalytic nanosystem. Nanoscale7, 7275–7283. 10.1039/c5nr00706b
22
FuS.WangS.ZhangX.QiA.LiuZ.YuX.et al. (2017). Structural effect of Fe3O4 nanoparticles on peroxidase-like activity for cancer therapy. Colloids Surf. B-Biointerfaces154, 239–245. 10.1016/j.colsurfb.2017.03.038
23
GaoL.ZhuangJ.NieL.ZhangJ.ZhangY.GuN.et al. (2007). Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. Nat. Nanotechnol.2, 577–583. 10.1038/nnano.2007.260
24
GaoS.LuX.ZhuP.LinH.YuL.YaoH.et al. (2019). Self-evolved hydrogen peroxide boosts photothermal-promoted tumor-specific nanocatalytic therapy. J. Mater. Chem. B7, 3599–3609. 10.1039/c9tb00525k
25
GokdumanK. (2019). Sensitization of cisplatin-resistant ovarian cancer cells by magnetite iron oxide nanoparticles: an in vitro study. Nanomedicine14, 3177–3191. 10.2217/nnm-2019-0126
26
GorgizadehM.AzarpiraN.LotfiM.DaneshvarF.SalehiF.SattarahmadyN. (2019). Sonodynamic cancer therapy by a nickel ferrite/carbon nanocomposite on melanoma tumor: in vitro and in vivo studies. Photodiag. Photodyn. Ther.27, 27–33. 10.1016/j.pdpdt.2019.05.023
27
GuptaR.SharmaD. (2020). Manganese-doped magnetic nanoclusters for hyperthermia and photothermal glioblastoma therapy. Acs Appl. Nano Mater.3, 2026–2037. 10.1021/acsanm.0c00121
28
HabibzadehS. Z.SalehzadehA.Moradi-ShoeiliZ.ShandizS. A. S. (2020). A novel bioactive nanoparticle synthesized by conjugation of 3-chloropropyl trimethoxy silane functionalized Fe3O4 and 1-((3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-(4-phenylth iazol-2-yl) hydrazine: assessment on anti-cancer against gastric AGS cancer cells. Mol. Biol. Rep.47, 1637–1647. 10.1007/s11033-020-05251-7
29
HauserA. K.AndersonK. W.HiltJ. Z. (2016a). Peptide conjugated magnetic nanoparticles for magnetically mediated energy delivery to lung cancer cells. Nanomedicine11, 1769–1785. 10.2217/nnm-2016-0050
30
HauserA. K.MitovM. I.DaleyE. F.McGarryR. C.AndersonK. W.HiltJ. Z. (2016b). Targeted iron oxide nanoparticles for the enhancement of radiation therapy. Biomaterials105, 127–135. 10.1016/j.biomaterials.2016.07.032
31
HeC.JiangS.JinH.ChenS.LinG.YaoH.et al. (2016a). Mitochondrial electron transport chain identified as a novel molecular target of SPIO nanoparticles mediated cancer-specific cytotoxicity. Biomaterials83, 102–114. 10.1016/j.biomaterials.2016.01.010
32
HeG.HeG.ZhouR.PiZ.ZhuT.JiangL.et al. (2016b). Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo. Biochem. Biophys. Res. Commun.469, 1075–1082. 10.1016/j.bbrc.2015.12.100
33
HeW.ZhouY.-T.WamerW. G.BoudreauM. D.YinJ.-J. (2012). Mechanisms of the pH dependent generation of hydroxyl radicals and oxygen induced by Ag nanoparticles. Biomaterials33, 7547–7555. 10.1016/j.biomaterials.2012.06.076
34
HeY.del ValleA.QianY.HuangY.-F. (2017). Near infrared light-mediated enhancement of reactive oxygen species generation through electron transfer from graphene oxide to iron hydroxide/oxide. Nanoscale9, 1559–1566. 10.1039/c6nr08784a
35
HighK. A.RoncaroloM. G. (2019). Gene therapy. N. Engl. J. Med.381, 455–464. 10.1056/NEJMra1706910
36
HuangG.ChenH.DongY.LuoX.YuH.MooreZ.et al. (2013). Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy. Theranostics3, 116–126. 10.7150/thno.5411
37
HuoM.WangL.ChenY.ShiJ. (2017). Tumor-selective catalytic nanomedicine by nanocatalyst delivery. Nat. Commun.8:357. 10.1038/s41467-017-00424-8
38
JahanbaniJ.GhotbiM.ShahsavariF.SeydiE.RahimiS.PourahmadJ. (2020). Selective anchoranticancer activity of superparamagnetic iron oxide nanoparticles (SPIONs) against oral tongue cancer using in vitro methods: the key role of oxidative stress on cancerous mitochondria. J. Biochem. Mol. Toxicol.34:e22557. 10.1002/jbt.22557
39
JohannsenM.ThiesenB.WustP.JordanA. (2010). Magnetic nanoparticle hyperthermia for prostate cancer. Int. J. Hyperthermia26, 790–795. 10.3109/02656731003745740
40
KankalaR. K.TsaiP.-Y.KuthatiY.WeiP.-R.LiuC.-L.LeeC.-H. (2017). Overcoming multidrug resistance through co-delivery of ROS-generating nano-machinery in cancer therapeutics. J. Mater. Chem. B5, 1507–1517. 10.1039/c6tb03146c
41
KeW.LiJ.MohammedF.WangY.TouK.LiuX.et al. (2019). Therapeutic polymersome nanoreactors with tumor-specific activable cascade reactions for cooperative cancer therapy. ACS Nano13, 2357–2369. 10.1021/acsnano.8b09082
42
KimJ.ChoH. R.JeonH.KimD.SongC.LeeN.et al. (2017). Continuous O2-evolving MnFe2O4 nanoparticle-anchored mesoporous silica nanoparticles for efficient photodynamic therapy in hypoxic cancer. J. Am. Chem. Soc.139, 10992–10995. 10.1021/jacs.7b05559
43
KleinS.KizalogluM.PortillaL.ParkH.RejekT.HuemmerJ.et al. (2018). Enhanced in vitro biocompatibility and water dispersibility of magnetite and cobalt ferrite nanoparticles employed as ros formation enhancer in radiation cancer therapy. Small14:e1704111. 10.1002/smll.201704111
44
KleinS.SommerA.DistelL. V. R.HazemannJ.-L.KroenerW.NeuhuberW.et al. (2014). Superparamagnetic iron oxide nanoparticles as novel X-ray enhancer for low-dose radiation therapy. J. Phys. Chem. B118, 6159–6166. 10.1021/jp5026224
45
KleinS.SommerA.DistelL. V. R.NeuhuberW.KryschiC. (2012). Superparamagnetic iron oxide nanoparticles as radiosensitizer via enhanced reactive oxygen species formation. Biochem. Biophys. Res. Commun.425, 393–397. 10.1016/j.bbrc.2012.07.108
46
KnowlesH. J.HarrisA. L. (2001). Hypoxia and oxidative stress in breast cancer hypoxia and tumourigenesis. Breast Cancer Res.3, 318–322. 10.1186/bcr314
47
KojimaK.TakahashiS.SaitoS.EndoY.NittamiT.NozakiT.et al. (2018). Combined effects of Fe3O4 nanoparticles and chemotherapeutic agents on prostate cancer cells in vitro. Appl. Sci. Basel8:134. 10.3390/app8010134
48
KumarC. S. S. R.MohammadF. (2011). Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv. Drug Deliv. Rev.63, 789–808. 10.1016/j.addr.2011.03.008
49
KumariS.BadanaA. K.GM. M.GS.MallaR. (2018). Reactive oxygen species: a key constituent in cancer survival. Biomark. Insights13:1177271918755391. 10.1177/1177271918755391
50
KuoS.-H.WuP.-T.HuangJ.-Y.ChiuC.-P.YuJ.LiaoM.-Y. (2020). Fabrication of anisotropic Cu ferrite-polymer core-shell nanoparticles for photodynamic ablation of cervical cancer cells. Nanomaterials10:2429. 10.3390/nano10122429
51
LaurentS.DutzS.HaefeliU. O.MahmoudiM. (2011). Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv. Colloid Interface Sci.166, 8–23. 10.1016/j.cis.2011.04.003
52
LeeK.-T.LuY.-J.MiF.-L.BurnoufT.WeiY.-T.ChiuS.-C.et al. (2017). Catalase-modulated heterogeneous fenton reaction for selective cancer cell eradication: SnFe2O4 nanocrystals as an effective reagent for treating lung cancer cells. ACS Appl. Mater. Interfaces9, 1273–1279. 10.1021/acsami.6b13529
53
LiW.-P.SuC.-H.ChangY.-C.LinY.-J.YehC.-S. (2016). Ultrasound-induced reactive oxygen species mediated therapy and imaging using a fenton reaction activable polymersome. ACS Nano10, 2017–2027. 10.1021/acsnano.5b06175
54
LiangC.ZhangX.ChengZ.YangM.HuangW.DongX. (2020). Magnetic iron oxide nanomaterials: a key player in cancer nanomedicine. View1:20200046. 10.1002/VIW.20200046
55
LiouG.-Y.StorzP. (2010). Reactive oxygen species in cancer. Free Radic. Res.44, 479–496. 10.3109/10715761003667554
56
LiuM.LiuB.LiuQ.DuK.WangZ.HeN. (2019a). Nanomaterial-induced ferroptosis for cancer specific therapy. Coord. Chem. Rev.382, 160–180. 10.1016/j.ccr.2018.12.015
57
LiuX.YanB.LiY.MaX.JiaoW.ShiK.et al. (2020). Graphene oxide-grafted magnetic nanorings mediated magnetothermodynamic therapy favoring reactive oxygen species-rebated immune response for enhanced antitumor efficacy. ACS Nano14, 1936–1950. 10.1021/acsnano.9b08320
58
LiuX.ZhengJ.SunW.ZhaoX.LiY.GongN.et al. (2019b). Ferrimagnetic vortex nanoring-mediated mild magnetic hyperthermia imparts potent immunological effect for treating cancer metastasis. ACS Nano13, 8811–8825. 10.1021/acsnano.9b01979
59
LiuX.-L.ChenS.ZhangH.ZhouJ.FanH.-M.LiangX.-J. (2019c). Magnetic nanomaterials for advanced regenerative medicine: the promise and challenges. Adv. Mater.31:1804922. 10.1002/adma.201804922
60
LiuY.ZhenW.JinL.ZhangS.SunG.ZhangT.et al. (2018). All-in-one theranostic nanoagent with enhanced reactive oxygen species generation and modulating tumor microenvironment ability for effective tumor eradication. ACS Nano12, 4886–4893. 10.1021/acsnano.8b01893
61
LudwigR.TeranF. J.TeichgraeberU.HilgerI. (2017). Nanoparticle-based hyperthermia distinctly impacts production of ROS, expression of Ki-67, TOP2A, and TPX2, and induction of apoptosis in pancreatic cancer. Int. J. Nanomed.12, 1009–1018. 10.2147/ijn.s108577
62
MaP.XiaoH.YuC.LiuJ.ChengZ.SongH.et al. (2017). Enhanced cisplatin chemotherapy by iron oxide nanocarrier-mediated generation of highly toxic reactive oxygen species. Nano Lett.17, 928–937. 10.1021/acs.nanolett.6b04269
63
MaX.WangY.LiuX.-L.MaH.LiG.LiY.et al. (2019). Fe3O4-Pd Janus nanoparticles with amplified dual-mode hyperthermia and enhanced ROS generation for breast cancer treatment. Nanoscale Horiz.4, 1450–1459. 10.1039/c9nh00233b
64
MaiT.HiltJ. Z. (2017). Magnetic nanoparticles: reactive oxygen species generation and potential therapeutic applications. J. Nanopart. Res.19:253. 10.1007/s11051-017-3943-2
65
MaiT.HiltJ. Z. (2019). Functionalization of iron oxide nanoparticles with small molecules and the impact on reactive oxygen species generation for potential cancer therapy. Colloids Surf. A-Physicochem. Eng. Aspects576, 9–14. 10.1016/j.colsurfa.2019.05.003
66
MaitiD.ZhongJ.ZhangZ.ZhouH.XionS.DongZ.et al. (2020). Polyoxomolybdate (POM) nanoclusters with radiosensitizing and scintillating properties for low dose X-ray inducible radiation-radiodynamic therapy. Nanoscale Hori.5, 109–118. 10.1039/c9nh00374f
67
MajiS. K.MandalA. K.NguyenK. T.BorahP.ZhaoY. (2015). Cancer cell detection and therapeutics using peroxidase-active nanohybrid of gold nanoparticle-loaded mesoporous silica-coated graphene. ACS Appl. Mater. Interfaces7, 9807–9816. 10.1021/acsami.5b01758
68
ManS.LiM.ZhouJ.WangH.ZhangJ.MaL. (2020). Polyethyleneimine coated Fe3O4 magnetic nanoparticles induce autophagy, NF-κB and TGF-β signaling pathway activation in HeLa cervical carcinoma cells via reactive oxygen species generation. Biomater. Sci.8, 201–211. 10.1039/c9bm01563a
69
MaryczK.MaredziakM.LewandowskiD.ZachanowiczE.ZiecinaA.WigluszR. J.et al. (2017). The effect of Co0.2Mn0.8Fe2O4 ferrite nanoparticles on the C2 canine mastocytoma cell line and adipose-derived mesenchymal stromal stem cells (ASCs) cultured under a static magnetic field: possible implications in the treatment of dog mastocytoma. Cell. Mol. Bioeng.10, 209–222. 10.1007/s12195-017-0480-0
70
MinH.QiY.ZhangY.HanX.ChengK.LiuY.et al. (2020). A graphdiyne oxide-based iron sponge with photothermally enhanced tumor-specific fenton chemistry. Adv. Mater.32:2000038. 10.1002/adma.202000038
71
MurphyM. P. (2009). How mitochondria produce reactive oxygen species. Biochem. J.417, 1–13. 10.1042/BJ20081386
72
OrelV. E.TselepiM.MitreliasT.RykhalskyiA.RomanovA.OrelV. B.et al. (2018). Nanomagnetic modulation of tumor redox state. Nanomed. Nanotechnol. Biol. Med.14, 1249–1256. 10.1016/j.nano.2018.03.002
73
OuM.PanC.YuY.WangX.ZhouY.ZhangH.et al. (2020). Two-dimensional highly oxidized ilmenite nanosheets equipped with Z-scheme heterojunction for regulating tumor microenvironment and enhancing reactive oxygen species generation. Chem. Eng. J.390:124524. 10.1016/j.cej.2020.124524
74
PalS.JanaN. R. (2020). Pharmacologic vitamin C-based cell therapy via Iron oxide nanoparticle-induced intracellular fenton reaction. Acs Appl. Nano Mater.3, 1683–1692. 10.1021/acsanm.9b02405
75
PandeyA.SinghK.SubramanianS.KordeA.SinghR.SawantK. (2020). Heterogeneous surface architectured pH responsive metal-drug nano-conjugates for mitochondria targeted therapy of glioblastomas: a multimodal intranasal approach. Chem. Eng. J.394:124419. 10.1016/j.cej.2020.124419
76
PardollD. M. (2012). The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer12, 252–264. 10.1038/nrc3239
77
ParkS.-M.AalipourA.VermeshO.YuJ. H.GambhirS. S. (2017). Towards clinically translatable in vivo nanodiagnostics. Nat. Rev. Mater.2:17014. 10.1038/natrevmats.2017.14
78
Pilar VinardellM.MitjansM. (2015). Antitumor activities of metal oxide nanoparticles. Nanomaterials5, 1004–1021. 10.3390/nano5021004
79
PrigersonH. G.BaoY.ShahM. A.PaulkM. E.LeBlancT. W.SchneiderB. J.et al. (2015). Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol.1, 778–784. 10.1001/jamaoncol.2015.2378
80
QiB.LiQ.MiaoL. (2016). Achieving enhanced NIR light-induced toxicity via novel hybrid magnetic nanoparticles. RSC Adv6, 61021–61028. 10.1039/c6ra10513k
81
RamalingamV.HarshavardhanM.KumarS. D.DeviS. M. (2020). Wet chemical mediated hematite α-Fe2O3 nanoparticles synthesis: preparation, characterization and anticancer activity against human metastatic ovarian cancer. J. Alloys Compd.834:155118. 10.1016/j.jallcom.2020.155118
82
Ranji-BurachalooH.GurrP. A.DunstanD. E.QiaoG. G. (2018). Cancer treatment through nanoparticle-facilitated fenton reaction. ACS Nano12, 11819–11837. 10.1021/acsnano.8b07635
83
SahuN. K.GuptaJ.BahadurD. (2015). PEGylated FePt-Fe3O4 composite nanoassemblies (CNAs): in vitro hyperthermia, drug delivery and generation of reactive oxygen species (ROS). Dalton Trans.44, 9103–9113. 10.1039/c4dt03470h
84
SchumackerP. T. (2006). Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell10, 175–176. 10.1016/j.ccr.2006.08.015
85
ShaikhS.YounisM.RehmanF. U.JiangH.WangX. (2020). Specific oxide nanoclusters enhance intracellular reactive oxygen species for cancer-targeted therapy. Langmuir36, 9472–9480. 10.1021/acs.langmuir.0c01378
86
SharmaR. A.PlummerR.StockJ. K.GreenhalghT. A.AtamanO.KellyS.et al. (2016). Clinical development of new drug-radiotherapy combinations. Nat. Rev. Clin. Oncol.13, 627–642. 10.1038/nrclinonc.2016.79
87
ShenZ.LiuT.LiY.LauJ.YangZ.FanW.et al. (2018). Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors. ACS Nano12, 11355–11365. 10.1021/acsnano.8b06201
88
ShiJ.KantoffP. W.WoosterR.FarokhzadO. C. (2017). Cancer nanomedicine: progress, challenges and opportunities. Nat. Rev. Cancer17, 20–37. 10.1038/nrc.2016.108
89
ShiY.WangJ.LiuJ.LinG.XieF.PangX.et al. (2020). Oxidative stress-driven DR5 upregulation restores TRAIL/Apo2L sensitivity induced by iron oxide nanoparticles in colorectal cancer. Biomaterials233:119753. 10.1016/j.biomaterials.2019.119753
90
SiddiquiM. A.WahabR.AhmadJ.FarshoriN. N.Al-KhedhairyA. A. (2020). Single and multi-metal oxide nanoparticles induced cytotoxicity and ROS generation in human breast cancer (MCF-7) cells. J. Inorg. Organomet. Polym. Mater.30, 4106–4116. 10.1007/s10904-020-01564-z
91
SilvaA. C.OliveiraT. R.MamaniJ. B.MalheirosS. M. F.MalavoltaL.PavonL. F.et al. (2011). Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int. J. Nanomed.6, 591–603. 10.2147/IJN.S14737
92
SongJ.LinL.YangZ.ZhuR.ZhouZ.LiZ.-W.et al. (2019). Self-assembled responsive bilayered vesicles with adjustable oxidative stress for enhanced cancer imaging and therapy. J. Am. Chem. Soc.141, 8158–8170. 10.1021/jacs.8b13902
93
SullivanR.AlatiseO. I.AndersonB. O.AudisioR.AutierP.AggarwalA.et al. (2015). Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol.16, 1193–1224. 10.1016/S1470-2045(15)00223-5
94
SwietekM.PanchukR.SkorokhydN.CernochP.FiniukN.KlyuchivskaO.et al. (2020). Magnetic temperature-sensitive solid-lipid particles for targeting and killing tumor cells. Front. Chem.8:205. 10.3389/fchem.2020.00205
95
TarangeloA.DixonS. J. (2016). An iron age for cancer therapy. Nat. Nanotechnol.11, 921–922. 10.1038/nnano.2016.199
96
ThenmozhiT. (2020). Functionalization of iron oxide nanoparticles with clove extract to induce apoptosis in MCF-7 breast cancer cells. 3 Biotech10:82. 10.1007/s13205-020-2088-7
97
ThoidingjamS.TikuA. B. (2019). Therapeutic efficacy of Phyllanthus emblica-coated iron oxide nanoparticles in A549 lung cancer cell line. Nanomedicine14, 2355–2371. 10.2217/nnm-2019-0111
98
TopalianS. L.HodiF. S.BrahmerJ. R.GettingerS. N.SmithD. C.McDermottD. F.et al. (2012). Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med.366, 2443–2454. 10.1056/NEJMoa1200690
99
TrachoothamD.AlexandreJ.HuangP. (2009). Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?Nat. Rev. Drug Disc.8, 579–591. 10.1038/nrd2803
100
VahrmeijerA. L.HuttemanM.van der VorstJ. R.van de VeldeC. J. H.FrangioniJ. V. (2013). Image-guided cancer surgery using near-infrared fluorescence. Nat. Rev. Clin. Oncol.10, 507–518. 10.1038/nrclinonc.2013.123
101
WangP.ShiY.ZhangS.HuangX.ZhangJ.ZhangY.et al. (2019a). Hydrogen peroxide responsive iron-based nanoplatform for multimodal imaging-guided cancer therapy. Small15:1803791. 10.1002/smll.201803791
102
WangS.LuoJ.ZhangZ.DongD.ShenY.FangY.et al. (2018). Iron and magnetic: new research direction of the ferroptosis-based cancer therapy. Am. J. Cancer Res.8, 1933–1946.
103
WangS.WangZ.YuG.ZhouZ.JacobsonO.LiuY.et al. (2019b). Tumor-specific drug release and reactive oxygen species generation for cancer chemo/chemodynamic combination therapy. Adv. Sci.6:1801986. 10.1002/advs.201801986
104
WangZ.JuY.AliZ.YinH.ShengF.LinJ.et al. (2019c). Near-infrared light and tumor microenvironment dual responsive size-switchable nanocapsules for multimodal tumor theranostics. Nat. Commun.10:4418. 10.1038/s41467-019-12142-4
105
WinstonG. W.GiulioR. T. D. (1991). Prooxidant and antioxidant mechanisms in aquatic organisms. Aquatic Toxicol.19, 137–161.
106
WuH.LiuL.SongL.MaM.GuN.ZhangY. (2019). Enhanced tumor synergistic therapy by injectable magnetic hydrogel mediated generation of hyperthermia and highly toxic reactive oxygen species. ACS Nano13, 14013–14023. 10.1021/acsnano.9b06134
107
WuH.YinJ.-J.WamerW. G.ZengM.LoY. M. (2014). Reactive oxygen species-related activities of nano-iron metal and nano-iron oxides. J. Food Drug Analy.22, 86–94. 10.1016/j.jfda.2014.01.007
108
XieY.JiangJ.TangQ.ZouH.ZhaoX.LiuH.et al. (2020). Iron oxide nanoparticles as autophagy intervention agents suppress hepatoma growth by enhancing tumoricidal autophagy. Adv. Sci.7:1903323. 10.1002/advs.201903323
109
XieY.LiuD.CaiC.ChenX.ZhouY.WuL.et al. (2016). Size-dependent cytotoxicity of Fe3O4 nanoparticles induced by biphasic regulation of oxidative stress in different human hepatoma cells. Int. J. Nanomed.11, 3557–3570. 10.2147/IJN.S105575
110
XiongR.ZhangW.ZhangY.ZhangY.ChenY.HeY.et al. (2019). Remote and real time control of an FVIO-enzyme hybrid nanocatalyst using magnetic stimulation. Nanoscale11, 18081–18089. 10.1039/c9nr04289j
111
YanagieH.OgataA.MitsuiS.HisaT.YamaseT.EriguchiM. (2006). Anticancer activity of polyoxomolybdate. Biomed. Pharmacother.60, 349–352. 10.1016/j.biopha.2006.06.018
112
YangC.-T.LiK.-Y.MengF.-Q.LinJ.-F.YoungI.-C.IvkovR.et al. (2018). ROS-induced HepG2 cell death from hyperthermia using magnetic hydroxyapatite nanoparticles. Nanotechnology29:375101. 10.1088/1361-6528/aacda1
113
YangK.ZhangS.ZhangG.SunX.LeeS.-T.LiuZ. (2010). Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett.10, 3318–3323. 10.1021/nl100996u
114
YeP.YeY.ChenX.ZouH.ZhouY.ZhaoX.et al. (2020). Ultrasmall Fe3O4 nanoparticles induce S-phase arrest and inhibit cancer cells proliferation. Nanotechnol. Rev.9, 61–69. 10.1515/ntrev-2020-0006
115
YinS.-Y.SongG.YangY.ZhaoY.WangP.ZhuL.-M.et al. (2019). Persistent regulation of tumor microenvironment via circulating catalysis of MnFe2O4@metal-organic frameworks for enhanced photodynamic therapy. Adv. Funct. Mater.29:1901417. 10.1002/adfm.201901417
116
YouC.GaoZ.WuH.SunK.NingL.LinF.et al. (2019). Reactive oxygen species mediated theranostics using a Fenton reaction activable lipo-polymersome. J. Mater. Chem. B7, 314–323. 10.1039/c8tb02947d
117
YuJ.ZhaoF.GaoW.YangX.JuY.ZhaoL.et al. (2019). Magnetic reactive oxygen species nanoreactor for switchable magnetic resonance imaging guided cancer therapy based on pH-sensitive Fe5C2@Fe3O4 nanoparticles. ACS Nano13, 10002–10014. 10.1021/acsnano.9b01740
118
ZanganehS.HutterG.SpitlerR.LenkovO.MahmoudiM.ShawA.et al. (2016). Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat. Nanotechnol.11, 986–994. 10.1038/nnano.2016.168
119
ZhangD.ZhaoY.-X.GaoY.-J.GaoF.-P.FanY.-S.LiX.-J.et al. (2013). Anti-bacterial and in vivo tumor treatment by reactive oxygen species generated by magnetic nanoparticles. J. Mater. Chem. B1, 5100–5107. 10.1039/c3tb20907e
120
ZhangP.WuG.ZhaoC.ZhouL.WangX.WeiS. (2020a). Magnetic stomatocyte-like nanomotor as photosensitizer carrier for photodynamic therapy based cancer treatment. Colloids Surf. B-Biointerfaces194:111204. 10.1016/j.colsurfb.2020.111204
121
ZhangT.LiY.HongW.ChenZ.PengP.YuanS.et al. (2019). Glucose oxidase and polydopamine functionalized iron oxide nanoparticles: combination of the photothermal effect and reactive oxygen species generation for dual-modality selective cancer therapy. J. Mater. Chem. B7, 2190–2200. 10.1039/c8tb03320j
122
ZhangY.FuX.JiaJ.WikerholmenT.XiK.KongY.et al. (2020b). Glioblastoma therapy using codelivery of cisplatin and glutathione peroxidase targeting siRNA from iron oxide nanoparticles. ACS Appl. Mater. Interfaces12, 43408–43421. 10.1021/acsami.0c12042
123
ZhangY.HaiY.MiaoY.QiX.XueW.LuoY.et al. (2020c). The toxicity mechanism of different sized iron nanoparticles on human breast cancer (MCF7) cells. Food Chem.341, 128263–128263. 10.1016/j.foodchem.2020.128263
124
ZhangY.XuY.SunD.MengZ.YingW.GaoW.et al. (2020d). Hollow magnetic nanosystem-boosting synergistic effect between magnetic hyperthermia and sonodynamic therapy via modulating reactive oxygen species and heat shock proteins. Chem. Eng. J.390:124521. 10.1016/j.cej.2020.124521
Summary
Keywords
ferrite nanoparticles, reactive oxygen species, cancer therapy, fenton reaction, external field, cascade reaction
Citation
Yu S, Zhang H, Zhang S, Zhong M and Fan H (2021) Ferrite Nanoparticles-Based Reactive Oxygen Species-Mediated Cancer Therapy. Front. Chem. 9:651053. doi: 10.3389/fchem.2021.651053
Received
08 January 2021
Accepted
09 March 2021
Published
27 April 2021
Volume
9 - 2021
Edited by
Jianhua Liu, Second Affiliated Hospital of Jilin University, China
Reviewed by
Ajay Singh Karakoti, The University of Newcastle, Australia; Lei Wang, Harbin Institute of Technology, China
Updates
Copyright
© 2021 Yu, Zhang, Zhang, Zhong and Fan.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Haiming Fan fanhm@nwu.edu.cn
This article was submitted to Nanoscience, a section of the journal Frontiers in Chemistry
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.